FELLOWS DAVID A 4
4 · Nightstar Therapeutics plc · Filed Jun 7, 2019
Insider Transaction Report
Form 4
FELLOWS DAVID A
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2019-06-07$10.76/sh−271,100$2,917,036→ 0 totalExercise: $14.74Exp: 2029-01-21→ Ordinary Shares (271,100 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-06-07$11.26/sh−220,000$2,477,200→ 0 totalExercise: $14.24Exp: 2028-01-30→ Ordinary Shares (220,000 underlying) - Disposition to Issuer
Ordinary Shares
2019-06-07$25.50/sh−617,090$15,735,795→ 0 total
Footnotes (3)
- [F1]The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the "Issuer") may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F2]In connection with the acquisition by Tungsten Bidco Limited of the entire issued and to be issued share capital of the Issuer on June 7, 2019 by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, all stock options were cancelled in exchange for a payment equal to $25.50 with respect to each ordinary share subject to the option award, less the applicable exercise price
- [F3]Represents the payment per share received in exchange for the cancellation of each option of $25.50, less the applicable exercise price.